Demarcated thresholds of tumor-specific CD8 T cells elicited by MCMV-based vaccine vectors provide robust correlates of protection

Author(s):
Nejad, E.B.; Ratts, R.B.; Panagioti, E.; Meyer, C.; Oduro, J.D.; Cicin-Sain, L.; Fruh, K.; Burg, S.H. van der (0000-0002-6556-0354); Arens, R.
Published
2019
Publication type
Article / Letter to editor
T cellsCancerCMV-based vaccine vectorPre-existing immunity
Date issued
2019-01-31
Language
English
Is part of
Journal for ImmunoTherapy of Cancer
hdl
1887/119500
doi
10.1186/s40425-019-0500-9